Merck (MRK) PT Raised to $114 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Joseph P. Schwartz raised the price target on Merck (NYSE: MRK) to $114.00 (from $107.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
